This supplemental application seeks additional funding to expand the RI-BRIN awarded to the URI to build an effective research base in the State of Rhode Island. The RI-BRIN has provided the means to develop a network of investigators, spanning seven Rhode Island institutions of higher education, to compete for NIH funding as well as acquire state-of-the-art instrumentation to conduct biomedical research. A primary focus of the RI-BRIN is to involve undergraduate institutions in biomedical research, and to help train and generate a diverse workforce that could serve the growing pharmaceutical and biotechnology industry in the State. Following the formation and establishment of this network, it was recognized that more support was needed to achieve the goals of the RI-BRIN and to enhance the research capacity of the State. The supplemental funding is requested to expand the current network to include new junior investigators, acquire equipment not previously requested, meet the needs of the bioinformatics core and mentoring activities, and complete the renovation of laboratory space. These efforts would further strengthen the competitiveness of existing investigators as well as provide a pool of new investigators to apply for NIH funding.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
3P20RR016457-02S1
Application #
6588299
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Program Officer
Liu, Yanping
Project Start
2001-09-30
Project End
2004-08-31
Budget Start
2002-09-17
Budget End
2003-08-31
Support Year
2
Fiscal Year
2002
Total Cost
$916,370
Indirect Cost
Name
University of Rhode Island
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
135531015
City
Kingston
State
RI
Country
United States
Zip Code
02881
Taylor, David L; Calabrese, Nicholas M (2018) Mercury content of blue crabs (Callinectes sapidus) from southern New England coastal habitats: Contamination in an emergent fishery and risks to human consumers. Mar Pollut Bull 126:166-178
Chen, Xiaodi; Hovanesian, Virginia; Naqvi, Syed et al. (2018) Systemic infusions of anti-interleukin-1? neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus. Brain Behav Immun 67:24-35
Paquin, Karissa L; Howlett, Niall G (2018) Understanding the Histone DNA Repair Code: H4K20me2 Makes Its Mark. Mol Cancer Res 16:1335-1345
Hahn, Mark E; Karchner, Sibel I; Merson, Rebeka R (2017) Diversity as Opportunity: Insights from 600 Million Years of AHR Evolution. Curr Opin Toxicol 2:58-71
Preiss, Matthew R; Cournoyer, Eily; Paquin, Karissa L et al. (2017) Tuning the Multifunctionality of Iron Oxide Nanoparticles Using Self-Assembled Mixed Lipid Layers. Bioconjug Chem 28:2729-2736
Tiwari, Rakesh K; Brown, Alex; Sadeghiani, Neda et al. (2017) Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors. ChemMedChem 12:86-99
Shimpi, Prajakta C; More, Vijay R; Paranjpe, Maneesha et al. (2017) Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. Environ Health Perspect 125:087005
Malloy, Thomas E; Kinney, Lorin (2017) Implications for the Self Determine Benevolence and Self-Protection in Intergroup Relations. Self Identity 16:171-193
Vierra, David A; Garzon, Jada L; Rego, Meghan A et al. (2017) Modulation of the Fanconi anemia pathway via chemically induced changes in chromatin structure. Oncotarget 8:76443-76457
Wan, Jerry; Lin, Fuquan; Zhang, Wei et al. (2017) Novel approaches to vitiligo treatment via modulation of mTOR and NF-?B pathways in human skin melanocytes. Int J Biol Sci 13:391-400

Showing the most recent 10 out of 376 publications